Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-043496)

Filing Details

Accession Number:: 0001209191-20-043496
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-23 17:00:09
Reporting Period:: 2020-07-21

Accepted Time:: 2020-07-23 17:00:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Oncternal Therapeutics Inc.	ONCT	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1265783	M Hazel Aker	12230 El Camino Real, Suite 300 San Diego CA 92130	Legal Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-21	41,972	$2.38	46,987	No	4	P	Indirect	By family trust.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By family trust.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2020-07-21	20,986	$2.38	20,986	$2.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,986		2026-01-21	No	4	A	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,284	Direct

Footnotes

The warrants are currently exercisable into shares of the Issuer's Common Stock except to the extent that the exercise would result in the beneficial ownership of more than 4.99% of the Issuer's outstanding Common Stock.